Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boileau

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2020
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURBLaura M Best, Belinda Williams, Bernard Le Foll, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 12, 2018
Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocolF Daniel Ramirez, Mouhannad M Sadek, Isabelle Boileau, et al.
Biological Psychiatry|October 12, 2024
Astrogliosis Marker [<sup>11</sup>C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive SymptomsJoeffre Braga, Emily J Y Kuik, Mariel Lepra, et al.
Translational Psychiatry|January 29, 2026
Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug developmentBernard Le Foll, Mickael Naassila, Jérôme Jeanblanc, et al.
Frontiers in Neural Circuits|November 6, 2023
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potentialRavinder Naik Dharavath, Celeste Pina-Leblanc, Victor M Tang, et al.
Translational Psychiatry|March 17, 2026
Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug developmentBernard Le Foll, Mickael Naassila, Jérôme Jeanblanc, et al.
Ebiomedicine|July 10, 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptomsYuhan Karida Liu, Devina Persaud, Erica L Vieira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2026
Assessment of noninvasive quantification of [<sup>18</sup>F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohortCarme Uribe, Lucas Narciso, Sang Soo Cho, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 18, 2023
Neuroimaging and Biosample Collection in the Toronto Adolescent and Youth Cohort Study: Rationale, Methods, and Early DataErin W Dickie, Stephanie H Ameis, Isabelle Boileau, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 8, 2020
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURBLaura M Best, Belinda Williams, Bernard Le Foll, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 12, 2018
Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocolF Daniel Ramirez, Mouhannad M Sadek, Isabelle Boileau, et al.
Biological Psychiatry|October 12, 2024
Astrogliosis Marker [<sup>11</sup>C]SL25.1188 After COVID-19 With Ongoing Depressive and Cognitive SymptomsJoeffre Braga, Emily J Y Kuik, Mariel Lepra, et al.
Translational Psychiatry|January 29, 2026
Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug developmentBernard Le Foll, Mickael Naassila, Jérôme Jeanblanc, et al.
Frontiers in Neural Circuits|November 6, 2023
GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potentialRavinder Naik Dharavath, Celeste Pina-Leblanc, Victor M Tang, et al.
Translational Psychiatry|March 17, 2026
Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug developmentBernard Le Foll, Mickael Naassila, Jérôme Jeanblanc, et al.
Ebiomedicine|July 10, 2026
Loss of vesicular monoamine transporter 2 in striatum of long COVID and relationship to neuropsychiatric symptomsYuhan Karida Liu, Devina Persaud, Erica L Vieira, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2026
Assessment of noninvasive quantification of [<sup>18</sup>F]SynVesT-1 with simplified reference tissue model 2 in an adolescent and youth cohortCarme Uribe, Lucas Narciso, Sang Soo Cho, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|November 18, 2023
Neuroimaging and Biosample Collection in the Toronto Adolescent and Youth Cohort Study: Rationale, Methods, and Early DataErin W Dickie, Stephanie H Ameis, Isabelle Boileau, et al.
Pageof 13